Paul Edward Kelly , Director at Relmada Therapeutics, holds 212.29K shares in Relmada Therapeutics (Ticker: RLMD). Most recently, Paul Edward Kelly Bought $25,000 shares of Relmada Therapeutics on Sep 11, 2024 for an estimated value of 64.75K.
What is the percentage of profitable transactions made by Paul Edward Kelly ?
The percentage of profitable transactions made by Paul Edward Kelly is 100%.
What is the average return per transaction made by Paul Edward Kelly ?
The average return per transaction made by Paul Edward Kelly is 296.50%.
What stocks does Paul Edward Kelly hold?
Paul Edward Kelly holds: RLMD stocks.
What was Paul Edward Kelly ’s latest transaction?
Paul Edward Kelly latest transaction was an Informative Buy of $64.75K.
What was Paul Edward Kelly 's most profitable transaction?
Paul Edward Kelly ’s most profitable transaction was an Informative Buy of RLMD stock on December 11, 2018. The return on the trade was 591.80%.
What is Paul Edward Kelly 's role in Relmada Therapeutics?
Paul Edward Kelly 's role in Relmada Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.